BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Stefano JT, Corrêa-Giannella ML, Ribeiro CMF, Alves VAF, Massarollo PCB, Machado MCC, Giannella-Neto D. Increased hepatic expression of insulin-like growth factor-I receptor in chronic hepatitis C. World J Gastroenterol 2006; 12(24): 3821-3828 [PMID: 16804965 DOI: 10.3748/wjg.v12.i24.3821]
URL: https://www.wjgnet.com/1007-9327/full/v12/i24/3821.htm
Number Citing Articles
1
Claudia Pivonello, Maria Cristina De Martino, Mariarosaria Negri, Gaia Cuomo, Federica Cariati, Francesco Izzo, Annamaria Colao, Rosario Pivonello. The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targetsInfectious Agents and Cancer 2014; 9(1) doi: 10.1186/1750-9378-9-27
2
Anna Alisi, Valentina Pampanini, Cristiano De Stefanis, Nadia Panera, Annalisa Deodati, Valerio Nobili, Stefano Cianfarani, Matias A. Avila. Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLDPLOS ONE 2018; 13(7): e0201566 doi: 10.1371/journal.pone.0201566
3
ALDONA KASPRZAK, AGNIESZKA ADAMEK. The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (Review)International Journal of Oncology 2012; 41(6): 1919 doi: 10.3892/ijo.2012.1666
4
Stephanie A. Osganian, Sonu Subudhi, Ricard Masia, Hannah K. Drescher, Lea M. Bartsch, Mark L. Chicote, Raymond T. Chung, Denise W. Gee, Elan R. Witkowski, Miriam A. Bredella, Georg M. Lauer, Kathleen E. Corey, Laura E. Dichtel. Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitisGrowth Hormone & IGF Research 2022; 65: 101482 doi: 10.1016/j.ghir.2022.101482
5
Yingxian Zhu, Xiaoyu Xiao, Guowei Li, Juyuan Bu, Wenying Zhou, Shaopeng Zhou. Isoflurane anesthesia induces liver injury by regulating the expression of insulin-like growth factor 1Experimental and Therapeutic Medicine 2017; 13(4): 1608 doi: 10.3892/etm.2017.4157
6
Xiuli Liu, Wei Jiang, Federico Aucejo, Richard Kim, Charles Miller, Michael Byrne, Rocio Lopez, Lisa Yerian. Insulin-like growth factor I receptor β expression in hepatocellular carcinomaHuman Pathology 2011; 42(6): 882 doi: 10.1016/j.humpath.2010.10.007
7
Aldona Kasprzak, Agnieszka Adamek, Wiesława Przybyszewska, Przemysław Pyda, Jacek Szmeja, Agnieszka Seraszek-Jaros, Agata Lanzafame, Anna Surdacka, Iwona Mozer-Lisewska, Maria Koczorowska. Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis CWorld Journal of Gastroenterology 2015; 21(13): 3867-3875 doi: 10.3748/wjg.v21.i13.3867
8
Sergey V. Gautier, Olga P. Shevchenko, Olga M. Tsirulnikova, Rivada M. Kurabekova, Irina E. Pashkova. Growth Hormone - Impact and Insights in Human Beings2023;  doi: 10.5772/intechopen.108301
9
R. M. Kurabekova, O. M. Tsirulnikova, S. Yu. Oleshkevich, I. E. Pashkova, G. A. Olefirenko. Impact of the growth hormone and IGF-1 on graft function and immune response in pediatric liver recipientsRussian Journal of Transplantology and Artificial Organs 2022; 24(2): 65 doi: 10.15825/1995-1191-2022-2-65-70
10
R I G Holt, P H Sönksen. Growth hormone, IGF‐I and insulin and their abuse in sportBritish Journal of Pharmacology 2008; 154(3): 542 doi: 10.1038/bjp.2008.99
11
Joan Oliva, Barbara A. French, X. Qing, Samuel W. French. The identification of stem cells in human liver diseases and hepatocellular carcinomaExperimental and Molecular Pathology 2010; 88(3): 331 doi: 10.1016/j.yexmp.2010.01.003
12
AGNIESZKA ADAMEK, ALDONA KASPRZAK, HANNA MIKOŒ, WIESŁAWA PRZYBYSZEWSKA, AGNIESZKA SERASZEK-JAROS, ARKADIUSZ CZAJKA, KAROLINA STERZYŃSKA, IWONA MOZER-LISEWSKA. The insulin-like growth factor-1 and expression of its binding protein-3 in chronic hepatitis C and hepatocellular carcinomaOncology Reports 2013; 30(3): 1337 doi: 10.3892/or.2013.2546
13
Laura E Dichtel, Kathleen E Corey, Joseph Misdraji, Miriam A Bredella, Melanie Schorr, Stephanie A Osganian, Brian J Young, Joshua C Sung, Karen K Miller. The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver DiseaseClinical and Translational Gastroenterology 2017; 8(1): e217 doi: 10.1038/ctg.2016.72
14
R. M. Kurabekova, O. M. Tsiroulnikova, I. E. Pashkova, L. V. Makarova, N. P. Mozheiko, A. R. Monakhov, O. P. Shevchenko. Association between Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) Levels, Liver Function and Short-Term Survival of Paediatric Liver RecipientsRussian Journal of Gastroenterology, Hepatology, Coloproctology 2020; 30(4): 44 doi: 10.22416/1382-4376-2020-30-4-44-51
15
Yutaka Takahashi. The Role of Growth Hormone and Insulin-Like Growth Factor-I in the LiverInternational Journal of Molecular Sciences 2017; 18(7): 1447 doi: 10.3390/ijms18071447
16
Richard J. Epstein, Thomas W. Leung. Reversing Hepatocellular Carcinoma Progression by Using Networked Biological TherapiesClinical Cancer Research 2007; 13(1): 11 doi: 10.1158/1078-0432.CCR-06-1619
17
Katrin Hoffmann, Alexander Johannes Nagel, Kazukata Tanabe, Juri Fuchs, Karolin Dehlke, Omid Ghamarnejad, Anastasia Lemekhova, Arianeb Mehrabi. Markers of liver regeneration—the role of growth factors and cytokines: a systematic reviewBMC Surgery 2020; 20(1) doi: 10.1186/s12893-019-0664-8
18
Laura E Dichtel, Kathleen E Corey, Melanie S Haines, Mark L Chicote, Allison Kimball, Caitlin Colling, Tracey G Simon, Michelle T Long, Jad Husseini, Miriam A Bredella, Karen K Miller. The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/ObesityThe Journal of Clinical Endocrinology & Metabolism 2022; 107(9): e3624 doi: 10.1210/clinem/dgac405
19
Anika Shimonty, Lynda F. Bonewald, Joshua R. Huot. Metabolic Health and Disease: A Role of Osteokines?Calcified Tissue International 2023; 113(1): 21 doi: 10.1007/s00223-023-01093-0
20
Howard D Strickler, Andrea A Howard, Marion Peters, Melissa Fazzari, Herbert Yu, Michael Augenbraun, Audrey L French, Mary Young, Stephen Gange, Kathryn Anastos, Andrea Kovacs. The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected womenAIDS 2008; 22(4): 527 doi: 10.1097/QAD.0b013e3282f22cdf
21
Yutaka Takahashi. Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver [Review]Endocrine Journal 2012; 59(11): 955 doi: 10.1507/endocrj.EJ12-0322
22
Hala M. Raslan, Yasser Elhosary, Wafaa M. Ezzat, Enas Abdel Rasheed, Maha A. Rasheed. The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, EgyptTransactions of the Royal Society of Tropical Medicine and Hygiene 2010; 104(6): 429 doi: 10.1016/j.trstmh.2010.01.012
23
Yasushi Adachi, Masanori Nojima, Mitsuru Mori, Yasutaka Matsunaga, Noriyuki Akutsu, Shigeru Sasaki, Takao Endo, Youichi Kurozawa, Kenji Wakai, Akiko Tamakoshi. Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control studyTumor Biology 2016; 37(11): 15125 doi: 10.1007/s13277-016-5360-z
24
Nathan Ford, Catherine Kirby, Kasha Singh, Edward J Mills, Graham Cooke, Adeeba Kamarulzaman, Philipp duCros. Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysisBulletin of the World Health Organization 2012; 90(7): 540 doi: 10.2471/BLT.11.097147
25
Kensaku Fukunaga, Hitomi Imachi, Jingya Lyu, Tao Dong, Seisuke Sato, Tomohiro Ibata, Toshihiro Kobayashi, Takuo Yoshimoto, Kazuko Yonezaki, Toru Matsunaga, Koji Murao. IGF1 suppresses cholesterol accumulation in the liver of growth hormone-deficient mice via the activation of ABCA1American Journal of Physiology-Endocrinology and Metabolism 2018; 315(6): E1232 doi: 10.1152/ajpendo.00134.2018